IBD Drive Time: Upadacitinib Therapy for Crohn’s Disease
Gastroenterology Learning Network
00:00
Benefits Outweigh Risks
The speakers discuss the concerns about relapse and loss of recapture with the use of OOPA for refractory Crohn's disease patients, ultimately concluding that the benefits outweigh the risks.
Transcript
Play full episode
